Laureano Sim News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Laureano Sim. Real-time updates on events, politics, business and more.

Ellipses Pharma and SunRock Biopharma Enter Into a Licensing Agreement for a First-in-class Bifunctional HER3:TRAIL Fusion Protein

May 25, 2022

Ellipses Pharma granted exclusive global rights to develop and commercialise SRB22, in solid tumours SunRock Biopharma S.L. ("SunRock"), a biopharmaceutical company that is developing a portfolio

City Of United Kingdom Sunrock Biopharma Kostenloser Wertpapierhandel Rajan Jethwa Juan Buela

Source: finanznachrichten.de

Ellipses Pharma and SunRock Biopharma enter into a licensing agreement for a first-in-class bifunctional HER3:TRAIL fusion protein

May 25, 2022

Ellipses Pharma and SunRock Biopharma enter into a licensing agreement for a first-in-class bifunctional HER3:TRAIL fusion protein&nbsp;Ellipses Pharma granted exclusive global rights to develop and commercialise SRB22, in solid tumours&nbsp;LONDON and SANTIAGO DE COMPOSTELA, Spain, May 25, 2022: SunRock Biopharma S...

City Of United Kingdom Sunrock Biopharma Rajan Jethwa Juan Buela Suzanne Wood

Source: pharmiweb.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Laureano Sim News Today

Ellipses Pharma and SunRock Biopharma Enter Into a Licensing Agreement for a First-in-class Bifunctional HER3:TRAIL Fusion Protein

Ellipses Pharma and SunRock Biopharma enter into a licensing agreement for a first-in-class bifunctional HER3:TRAIL fusion protein

Explore More Categories